THEGLAUCOMAFOUNDATION

NEWSLETTER

S U M M E R 2 0 0 9

The Nutrition FactorThe importance of nutrition inprotecting you from serious illnesseshas been well documented. Much hasalso been written about foods andsupplements that might protect youreyes. Before you considerincorporating nutritionaltherapy into your glaucomatreatment regimen, it isimportant to consult yourgeneral physician.

While no conclusive studies prove aconnection between specific foods ordrinks and glaucoma, it has beensuggested that foods rich in the antiox-idants lutein and zeaxanthin may bethe most effective in protecting thehealth of the eye. Foods high in luteininclude egg yolks, kale, spinach,broccoli, corn and peas and other fruitsand vegetables. Zeaxanthin is found inmany of these same foods, but orangesand corn contain more zeaxanthin thanlutein.

It is also believed that individuals witha high intake of omega-3 fatty acidsmay have a lower incidence of certaineye diseases. Good sources are cold-water fish, such as salmon, cod andmackerel, black currant seed oil andflaxseed oil.

An early study suggested that peoplewho drank red wine in moderationmight be less likely to develop age-related macular degeneration. Laterstudies have not supported thesefindings. Some believe that resveratrol,an ingredient in red wine, may confersome beneficial ocular effects.

There are anecdotal and unconfirmedreports that excessive caffeine intakemay, in some patients, cause mild tomoderate elevations of IOP.

Eating more fruits and vegetables mayor may not be protective for glaucoma,but it’s definitely protective for theheart and helps prevent other diseases.

A better diet should also improve thehealth of the blood vessels, and theynourish the optic nerve, so this kind ofchange certainly can be positive.

Supplements and VitaminsA balanced diet is the best way toensure you are getting an appropriatesupply of essential vitamins andminerals. If you are concerned that youare not getting sufficient nutrientsfrom the food you eat, you may wantto talk to your doctor about taking amultivitamin or multimineral nutritionalsupplement. Some of the vitamins andminerals that may be good for the eyesare zinc and copper, and antioxidantvitamins C, E, and A. But studies thusfar show no effect on IOP. Whilemassive doses of vitamin C may lowerIOP, such high doses bring otherpotential problems, as does too muchvitamin A, which can cause headaches,vision problems, nausea, etc.

Where herbal remedies are concerned,gingko biloba is an antioxidant and anearly study indicated it appeared toimprove visual field. However, furtherstudies are needed to determine anyproven effects. Gingko biloba increasesocular blood flow and may provide aneuroprotective effect. Bilberry issupposed to promote optic nervehealth, but again, there is no evidenceto support this claim. Moderately long-term studies have shown that marijuanahas no proven effect on glaucoma.

continued page 7

Nutrition, Exercise and Glaucoma

2

Dear Friends:

I write this as we are about to leave for Boston, where The GlaucomaFoundation is participating in the 2009 World Glaucoma Congress. It clearlydoes take a global exchange of knowledge to meet the challenges of findingnew treatments and ultimately eliminating blindness from glaucoma. TGF isplaying an increasingly active role in this growing international community.

Our own primary international event is the renowned Scientific Think Tank,which each year brings researchers, scientists and clinicians from differentdisciplines together to consider a compelling issue relating to glaucoma. Aswe know, glaucoma is a group of diseases that share a common endpoint – aspecific type of damage to the optic nerve. This October the 2009 Think Tankwill sharply focus on one type of glaucoma, with its theme, “ExfoliationSyndrome: The First Potentially Curable Glaucoma.” We’ll report on thatgathering in a future issue.

Providing seed grants so that researchers can give innovative ideas a chanceto show they have merit has been at the heart of The GlaucomaFoundation’s mission since we awarded our first grants in 1985. We have justsurveyed grantees from the past 10 years to gauge the impact our fundinghas had on their research. It is most encouraging that so many responsesindicate initial funding received from TGF was crucial in launching theirresearch, which in many cases led to larger government grants.

Another focus of our mission is educating the public about glaucoma andliving with the disease. We hope you find the articles in this “Eye to Eye”useful and interesting.

We thank all our supporters for making the important programs andinitiatives of TGF possible. We are counting on your continued generosityduring these difficult times.

Sincerely,

Scott R. ChristensenPresidentChief Executive Officer

BOARD OF DIRECTORS

Gregory K. Harmon, MDChairman of the Board

Joseph M. LaMottaChairman Emeritus

Robert Ritch, MDMedical Director, Vice President & SecretaryProfessor & Chief, Glaucoma ServiceThe New York Eye and Ear Infirmary

William C. Baker

Stephen D. Barkin

Joseph M. CohenChairmanJ.M. Cohen & Company

Peter J. Crowley

David G. CushmanSenior Vice President/Regional ManagerOrvis/Cushman & Wakefield of California, Inc.

Rutledge Ellis-Behnke, PhDAssociate ProfessorMassachusetts Institute of Technology

David FellowsPresident, Vision Care New VenturesVistakon

Murray Fingeret, ODChief, Optometry SectionSt. Albans VA Medical Center

Barry FriedbergFriedbergMilstein, LLC

Ilene Giaquinta

Debora K. Grobman, Esq.

Barbara W. Hearst

Chuck F.V. ImhofStaff Vice President, New York SalesDelta Airlines, Inc.

Gerald Kaiser, Esq.

Paul L. Kaufman, MDProfessor of Ophthalmology & Visual SciencesDirector, Glaucoma ServiceUniversity of Wisconsin-Madison

Theodore Krupin, MDProfessor of OphthalmologyNorthwestern University Medical School

Susan LaVentureExecutive DirectorNational Association for Parents of Children with Visual Impairments

Martin R. LewisMartin R. Lewis Associates

Jeffrey M. Liebmann, MDClinical Professor of OphthalmologyDirector, Glaucoma ServiceManhattan Eye, Ear & Throat Hospital

Maurice H. Luntz, MDEmeritus Clinical ProfessorThe Mount Sinai School of MedicineEmeritus Director Glaucoma ServiceManhattan, Eye, Ear & Throat Hospital

Kenneth Mortenson

Susan A. Murphy

Sheldon M. Siegel

James C. Tsai, MDProfessor & ChairmanDepartment of Ophthalmology & Visual ScienceYale School of Medicine

Mary Jane Voelker

Irving Wolbrom

Alcon Laboratories, Inc.Robert WarnerVice President, U.S. Pharmaceutical Products

Allergan, Inc.Julian GangolliCorporate Vice PresidentPresident, North American Pharmaceuticals

Pfizer, Inc.Dennis KowalskiDirector/Team Leader – US MarketingOphthalmic & Endocrine Care

PRESIDENT & CHIEF EXECUTIVE OFFICER

Scott R. Christensen

Letter from the President

3

Doctor, I Have a Question.

??DIHAQ

Questions answered by:Dr. Murray FingeretProfessorSUNY College of OptometryMember of the TGF Medical Advisory Board

?

What should I do if my medicationis no longer manufactured or Ireceive a different bottle? Several brand name medications (Trusopt,CoSopt, Alphagan, and Timoptic) have recentlybecome available generically. At times, yourdrug plan may replace your drug with itsgeneric equivalent without informing theindividual, leading to confusion. If you receive adrug you are not familiar with, check to see if itis the generic equivalent by comparing the oldand new bottles. The generic equivalents of theabove named drugs are dorzolamide, timolol-dorzolamide, brimonidine, and timolol. Tofurther complicate the matter, the cap colors ofsome of the generic drugs are different thanthe original agents. If your medication haschanged or appears to have been discontinued,speak with your doctor immediately.

What is the relationship betweensteroids and glaucoma?

Steroids are medications with a wide variety ofuses, not only in eyecare, but to treat illnessesincluding breathing disorders, such as asthma,and inflammatory diseases, for examplearthritis. Steroids can be taken in the form ofpills, creams, eye drops, breath inhalers,injections or nasal sprays. It is understood thatsteroids can cause elevation of the intraocularpressure. Topical ocular administration of

steroids is the most likely to cause elevation ofIOP. But any form can cause a rise in eyepressure in persons with glaucoma or at risk forthe disease. People with or at risk for glaucomashould have their IOP measured periodicallywhile on steroid treatment. All individualsshould have an eye exam if steroids – eveninhalers or skin preparations – are to be usedon a long-term basis. It’s important for the eyedoctor and general physician to work togetherso treatment can be started or advanced tocompensate for the rise in pressure.

Is it okay to suspend medication ifit has adverse side effects?

All medications have some potential sideeffects. Since glaucoma eye drops can beabsorbed systemically, these side effects canaffect both the eye and the body. Some, such asan initial stinging sensation, are bothersome.Others can be more serious. Every patientshould contact his or her physician to determinewhether a side effect warrants discontinuing amedication. If you believe your side effect isserious and you can not reach your doctor, it isbetter to skip a dose until you have a chance toreview the options with your doctor.

4

World Glaucoma Day (WGD) on March 12,the second annual observance, once againwas immensely successful, with over 2,000activities having been reported. Among theactivities:screenings,educationalprograms, andother eventstaking place inAustralia, Asia,Africa, Europe,North and SouthAmerica.

Leading up toWGD, TheGlaucomaFoundation co-sponsored aCongressionalBriefing onCapitol Hill onMarch 10th. TGFBoard MemberMurray Fingeret was one of the two NEI-funded researchers who described thedisease, its incidence and economic burden aswell as the latest research.

On the following day, March 11th, to focuson the need for international awareness, TheGlaucoma Foundation co-sponsored a

glaucoma screening at the United Nationsheadquarters in New York. The day wasspearheaded by Dr. Robert Ritch, TGFMedical Director, who is head of Glaucoma

Service at New York Eye and EarInfirmary. Ambassadors, deputyambassadors and staff were invited tothe free screening. Over 400individuals from some 95 countriesaround the globe were tested andprovided with their results, whichindicated whether they hadglaucoma, were a glaucoma suspect,or had normal eyes. More than 30doctors, technicians and volunteers

assisted with theUN screenings.

While at theUnited Nations,Scott Christensenwas interviewedon icastNews.com’s“Live and Directfrom the UnitedNations.” That

interview by the New York Bureau Chief ofthe ITAR-Tass News Agency is available onTGF’s website atwww.glaucomafoundation.org/news.htm.

Robert Ritch, MD, examinesVanu Gopala Menon,Ambassador to the UnitedNations from Singapore.Among the volunteer staff onhand were (left to right)Gustavo deMoraes, MD, anNYEE glaucoma fellow; andScott Christensen, President ofThe Glaucoma Foundation.

A Global Observance

Scott Christensen being interviewed at theUnited Nations.

At the United Nations Glaucoma Screenings from left, Nathan M. Radcliffe, MD; TGF Board Member Murray Fingeret, OD; FrankAshburn, MD; TGF Founder and Medical Director Robert Ritch, MD.

5

“I’ve beendealing withmy eyesightmost of my

life,” says Susan Genis, a formercriminal lawyer who today is aninstructor and practitioner of Anusarayoga. “In the first grade, I found out Iwas nearsighted and had to getglasses. In my 20s, I developed uveitis, achronic inflammation within the eyethat can lead to glaucoma. Physically,I’m feeling better than I have in years.

“There were many horrible proceduresalong the way involving a lot ofsteroids, which can provoke glaucomaand also cataracts. I’ve had surgeriesand a shunt in one eye. There’s a lot ofdamage, with almostno vision in one eye.And I’m losing visionin the other eye. Thethought of losing mysight completely isterrifying, but I justseem to be good atdealing with what Ihave.”

As a lawyer, Susanworked with afederal judge andlater in the DA’s office. It got moredifficult being a lawyer as she lostvision, but that isn’t why she stopped.She started practicing yoga as a stressrelease. She got to the point where sheknew she had to make a change, andshe had to leave her job to figure outwhat she would do.

“I found myself doing more yoga,occasionally substituting for another

teacher. And I became a vegetarian inthe late 1970s. Then, about five yearsago I was introduced to Anusara yoga– a way of teaching and studying yogathat encompasses a yoga philosophyand life view with physical alignment.Anusura yoga teaches that life is goodand its essence is joy and freedom – it’sa celebration of these qualities. Itmade a lot of sense to me. All of thishas totally changed my body and mypractice.

“Today I’m a certified teacher at asmall yoga studio in New York City. Ialso teach a lot of seniors – sometimeschair yoga. I work with several organi-zations and have private clients too.And then I study. I feel better. While

there’s no real evidencethat my yoga helps myeyesight, it helps memaintain things; it keepsme feeling fit.”

Early on, Susan heard aboutthe New York GlaucomaSupport and EducationGroup, now chaired byEdith Marks and JaniceEwenstein. “It’s been veryhelpful. Even today, when Ihave a complication that I

have to face, I return to the group toask about the experiences of others,doctors, etc.” And she volunteers atthe TGF office to help with the mailingof the group’s newsletter. That supportgroup now operates as the New YorkChapter of The Glaucoma Foundation.“It’s growing, with a more diverse andyounger membership,” Susan notes.

The LifestyleConnectionA Conversation with Susan Genis

Susan Genis

New Board Members

Barry S. Friedberg Barry S. Friedberg isPresident and CEO ofFriedbergMilstein, LLC, anindependent investmentmanagement firm. Prior tothat, he was an ExecutiveVice President of Merrill Lynch & Co., Inc. anda member of the firm’s ExecutiveManagement Committee. He was responsiblefor management of the Investment BankingGroup from January, 1985 until May, 1993.

Mr. Friedberg began his career in l963 withChemical Bank. In 1964 he joined A.G.Becker, which was acquired by Merrill Lynchin 1984.

Mr. Friedberg is on the Board of Directors ofNew York Private Bank & Trust Corp., GoldenBear, and Yoostar, and he serves as an advisorto Crestview Partners, a private equity firm.He was Chairman of the Board of the NewYork City Ballet from 2003 to 2008. Duringthis period, he also served on the Board ofLincoln Center for the Performing Arts. He isChairman Emeritus of the Board of New YorkCity Ballet, and a member of the Board ofDirectors of Boys & Girls Harbor, Inc.

Raised in Baltimore, Maryland, he is agraduate of Princeton University and lives inNew York City.

Robert K. Warner Robert K. Warner is VicePresident of U.S.Pharmaceutical Productsfor Alcon Laboratories, Inc.,headquartered in FortWorth, Texas. In this rolehe today leads GlobalPharmaceutical Marketing,Ophthalmic and SpecialtyEye & Ear Sales, Managed Care and FalconPharmaceuticals.

Born in New York City, he attended PaceUniversity, graduating in 1987 with aBachelor of Science degree in chemistry.After working as a research developmentchemist at Sun Chemical, Inc., he decided topursue his growing interest in business. Hereturned to school and in 1993 obtained his

MBA in finance from Rutgers University,Newark, NJ.

Mr. Warner joined Alcon in 1993 as a salesrepresentative and quickly rose through theranks. With a strong track record, in 1997 hejoined Pharmaceutical Marketing. His nextmove was to the new position of GlobalDirector, Anti-Infectives, Anti-Inflammatories,Combinations, and Otic products in 2000.

In 2004, he was promoted to Director, GlobalPharmaceutical Marketing, responsible forthe worldwide marketing of Alcon’s then $2billion pharmaceutical portfolio. In 2006 hewas appointed Vice President, GlobalPharmaceutical Marketing and in 2007received a promotion to his current position.

New Scientific Advisory Board Member

Gülgün Tezel, MD Gülgün Tezel, M.D., isprofessor in thedepartments ofOphthalmology & VisualSciences and AnatomicalSciences & Neurobiologyat the University ofLouisville, Kentucky. Sheobtained her medical degree and completedher ophthalmology residency in Turkey andbegan her career in clinical practice in 1989.During a ten-year period, she saw thatdespite her best efforts to lower IOP, in manyglaucoma patients the disease continued toprogress. This led her to leave her practice tojoin a research team at WashingtonUniversity in St. Louis. In 1999, she joined thefaculty there. She established her newlaboratory at the University of Louisville in2002. Dr. Tezel’s work has brought newinsights into the molecular mechanisms andtreatment possibilities for glaucoma. Heraccomplishments have resulted in numerousscientific publications; she has been areviewer for many leading journals andgranting agencies. Currently principalinvestigator for two National Eye Instituteresearch projects, she is the recipient of theResearch to Prevent Blindness Sybil B.Harrington Scholars Award and the WorldGlaucoma Association Potential FutureImpact Award.

6

7

The best advice: have your eyes tested regularly,follow the medication regimen you have establishedwith your glaucoma doctor, and discuss anyalternative therapies with your physicians.

ExerciseA daily routine of exercise is a good prescription foranyone. But again, before embarking on a newexercise regime, always discuss the pros and conswith your physician.

There is some evidence that aerobic exercise (e.g.,brisk walking, running, biking, dancing) performedon a regular basis can lower IOP. To reduce your IOP,you should spend about 30 minutes doing aerobicexercise at least four days a week.

Exercise may also improve blood flow to the retinaand optic nerve. If you need an incentive, rememberthat once the aerobic exercise stops, your IOP willreturn to its previous levels.

There are some caveats. When patients withpigmentary dispersion syndrome or pigmentaryglaucoma jog or participate in other jarring sports,

they may develop an exercise-induced release ofpigment from the iris and possibly an associatedspike in IOP. These patients need to check with theirophthalmologist, who may want to evaluate themboth before and after an exercise session.

If you have diabetes and take oral medication orinsulin, your doctor will need to adjust your dose soyour blood sugar does not fall too low during andafter exercise. Remember, upside-down yogapositions, scuba diving, bungee jumping and otheractivities where you invert your body should beavoided, because they can raise IOP. Exercises inwhich you inhale and then hold your breath – suchas weightlifting – appear to have a negative impacton IOP as well.

It’s important to stay hydrated while exercising.Drink water before, during and after your workout.Although patients with glaucoma need water asmuch as anyone else, it is important not to drinklarge quantities of fluids too quickly, as that willcause a temporary rise in IOP.

Nutrition, Exercise and Glaucoma continued from page 1

TGF Reaching New AudiencesLunch and Learn Events There are new ways to become a friend of TheGlaucoma Foundation and advocate for glaucomaawareness. If you are active in your community orworkplace, consider hosting a “Lunch and Learn”event. Arrange a presentation for a local organi-zation, social group, business office or any venuewith an audience of 50 to 75 people. The GlaucomaFoundation will provide aknowledgeablespokesperson to attend.These “Lunch and Learn”programs are presented as afree community service ofTGF and there are no feesinvolved. For additionalinformation, email KiraZmuda at kzmuda@glauco-mafoundation.org.

Help TGF on eBayeBay Giving Works was created to enable eBaybuyers and sellers to help causes and non-profitsthat matter to them. As of mid-2009, more than

$126 million has been received worldwide througheBay Giving Works. If you have something to sell oneBay, we hope you will list the item to benefit TheGlaucoma Foundation and commit to donating apercentage of your listing’s final sale price to TGF. Ifyou’re an eBay member with a PayPal account, youcan make an immediate online cash donation toTGF. You’ll find a link to TGF on eBay by clicking on

the “Support Us” tab atwww.glaucomafoundation.org.

New Facebook PresenceWhile you’re online, check outTGF’s Facebook page. If you’renot already a member, sign upas a TGF fan. Read what ourfriends are saying. Learn aboutactivities we’re planning. Seewhat we are up to at TheFoundation. It’s a great place tokeep on top of things. You’ll

find a link to the TGF Facebook page by clicking onthe “Support Us” tab at www.glaucomafoun-dation.org.

8

WE NEEDYOUR SUPPORTYes, I support The Glaucoma Foundation’s work in

pursuit of new treatments and cures for glaucoma.Enclosed is my tax-deductible gift of:

■ $25 ■ $50 ■ $100 ■ $250 ■ $500

■ $1000 ■ Other $__________

Please make checks payable to: The Glaucoma Foundation

NAME

ADDRESS

CITY STATE ZIP

PHONE

EMAIL

CREDIT CARD GIFT

Gifts may be made with Visa, MasterCard, or American Express.

CREDIT CARD #

EXPIRATION

SIGNATURE

■ Please do not share my name with other organizations.*

The Glaucoma Foundation80 Maiden Lane, Suite 700 • New York, NY 10038

* In order to locate additional supporters, The Foundation occasionally trades mailing lists with other non-profit organizations.Checking this box will ensure that The Glaucoma Foundation never trades your address. [50-2009]

✄With Your Support…TGF Answers the Call ofPromising ResearchFor years, we have stated that researchersfunded with TGF seed grants frequently usepreliminary data from their investigations tosupport proposals for larger grants from suchfunding sources as the National Institutes ofHealth (NIH). A new TGF survey of recentgrantees confirms that assertion.

According to 50 surveys, 27 grantees usedpreliminary data from early work funded byTGF to establish the basis for a subsequent NEIgrant and 23 grantees used their data toestablish the basis for other major funding.

One researcher stated: “The initial funding wereceived from The Glaucoma Foundation wasabsolutely critical to our ability to gather thedata and supporting publications necessary tobe competitive for funding by the National EyeInstitute at NIH…” Wrote another: “TGF’sgenerous support and funding was essential toachieve our goals and has opened up manyexciting avenues of research in my laboratoryfocusing on why retinal ganglion cells die inglaucoma and what can we do to save them.”

Private donations remain critical for TheGlaucoma Foundation to fund promisingresearch projects that can bring us closer tofinding new therapies and eventually a cure forglaucoma. Please be as generous as you can be.

We are currently seeking gift bag and auction item donations for our

Annual Black + White Ball onDecember 2, 2009

If you have any items, suggestions orquestions, please contact Kira Zmudakzmuda@glaucomafoundation.org.

Letter from the President

Eye to Eye is published three times per year by The Glaucoma Foundation.

Editor: Gabrielle Bamberger Designer: Lisa Grey

N e w Yo r k C i t y C h a p t e r The Glaucoma Support and Education Group completed a very successful 2008/09 season thatended with a visit to the National Association of the Visually Handicapped, a must visit forthose with glaucoma. It's an opportunity to learn about the visual aids available.

Plans for the 2009/10 season are currently underway. The lineup will include workshops onglaucoma treatment, medications, laser and surgical treatment, nutrition, recommendedexercises and much more. The opening meeting will be held on Saturday, September 26, at 11am. Dr. James Tsai will speak on “Current Directions for the Management of Glaucoma.” Allmeetings are free and open to the public. The meetings take place at The New York Eye andEar Infirmary located at 310 East 14th Street, Manhattan. If you would like to be involvedwith the NYC Chapter please email kzmuda@glaucomafoundation.org.

L o n g I s l a n d ( N Y ) C h a p t e r

The Long Island Chapter of The Glaucoma Foundation is planning its first outreach initiativefor Saturday, November 14, at a site to be determined in central Nassau County. The Chapteris reaching out to area glaucoma specialists and is planning a workshop format from 10 am tonoon, with a keynote address, presentations, and a final question and answer session.Following this event, periodic meetings will be scheduled at which Long Island ophthalmol-ogists will give presentations on topics of interest. If you would like to be involcved with theLong Island Chapter please email kzmuda@glaucomafoundation.org.

N e w E n g l a n d C h a p t e r

The New England Chapter is planning a varied format for its meetings for the seasonbeginning in the fall. In September, there will be a lecture followed by a support groupmeeting. October will be devoted to pediatric glaucoma. The lecture series will continue inNovember and January with a support group meeting following each presentation. Speakerswill talk about gene research and indications for trabeculectomy and for laser surgery in thetreatment of glaucoma. There will be no meeting in December. Dates and speakerinformation will be available on The Glaucoma Foundation website or by emailingcduffek@glaucomafoundation.org.

C h i c a g o C h a p t e r

The Chicago Chapter ended its season with a meeting on June 23rd. Dr. Julia Agapov ofMadison, Wisconsin, spoke on “Glaucoma Medication and How to Properly Administer It.”Programs will be held again in the fall. The chapter has been reaching out to Chicago areadoctors and patients who would like to become involved and participate in the chapter’s work – in outreach, program planning, and educational presentations to local glaucomapatients. If you would like to be involved with the Chicago Chapter please emailchicago@glaucomafoundation.org or kzmuda@glaucomafoundation.org.

CHAPTERC O R N E R

9

NON PROFIT ORG.U.S. POSTAGE

PAIDPERMIT NO. 60

FARMINGDALE, NY11735

A copy of The Glaucoma Foundation’s annual financial report may be obtained upon request by writing to The Foundation at 8o Maiden Lane, Suite 700, New York, NY 10038 or by residents of the states listed below from the appropriate state agency.Florida: A copy of the official registration and financial information may be obtained from the Division of Consumer Services by calling toll-free within the State .Registration Number - CH7263. Registration does not imply endorsement, approval, orrecommendation by the State. Maryland: Information filed under the Maryland Charitable Organizations Laws can be obtained for the cost of postage and copies from the Office of the Maryland Secretary of State, Statehouse, Annapolis, MD 21401 or bycalling 410-974-5534. Mississippi: Mississippi Secretary of State’s Office, Charities registration, PO Box 136, Jackson, MS 39205-0136, 601-359-1633. New Jersey: Information filed with the Attorney General concerning this charitable solicitation may beobtained from the Attorney General of the State of New Jersey by calling 201-504-6215. Registration with the Attorney General does not imply endorsement. New York: A copy of the last annual report filed may be obtained upon request in writing tothe Office of the Attorney General, Department of Law, Charities Bureau, 120 Broadway, New York, NY 10271. North Carolina: A copy of the license to solicit charitable contributions as a charitable organization or sponsor and financial information maybe obtained from the Department of Human Resources, Solicitation Licensing Branch, by calling 919-733-4510. Registration does not imply endorsement, approval, or recommendation by the State. Pennsylvania: The official registration and financialinformation of The Glaucoma Foundation may be obtained from the Pennsylvania Department of State by calling toll free, within Pennsylvania, 1-800-732-0999. Registration does not imply endorsement. Virginia: Official registration and financialinformation of The Glaucoma Foundation may be obtained from the State Division of Consumer Affairs, Department of Agriculture & Consumer Services, P.O. Box 1163, Richmond, VA 23209. Washington: Registration and financial report informationmay be obtained from the Charities Division, Office of the Secretary of State of Washington, Olympia, WA 98504-0422 or by calling 1-800-332-4483. West Virginia: West Virginia residents may obtain a summary of the registration and financialdocuments from the Secretary of State, State Capitol, Charleston, WV 25305. Registration does not imply endorsement.

S U M M E R2 0 0 9

Funding for this newsletter generously provided by ALLERGAN, INC.

The Glaucoma Foundation80 Maiden Lane, Suite 700 New York, NY 10038www.glaucomafoundation.orgT 212.285.0080 F 212.651.1888

Change

• Start your trip with new refills of your glaucomamedications.

• Carry medications with you on an airplane insteadof storing them in your checked luggage whichcan be lost.

• Store all medications in a dark, cool area, forexample, among or inside clothing.

• For air travel, pack eye drops, with other liquids,in a one-quart, zip-top plastic bag in 3-ounce orsmaller containers. (Recently relaxed TSAregulations permit carry-on of unlimitedquantities of medications on commercial aircraftin the United States, Declare these items forinspection at the checkpoint.)

• To simplify your medication regimen whiletraveling, set up an alarm on your cellular phone,watch or travel alarm clock to remind you whento take your daily doses.

• Many doctors recommend adapting yourmedication schedule to the local time at yourdestination and not worrying about a misseddosage due to time zone changes. Ask yourdoctor to be sure.

• And don’t forget: make a list of all yourmedications, noting each prescription dosage, themedication’s trade name as well as its genericname – especially important if you are travelingabroad.

TGF’s Annual Rx Travel Tips